Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Proteins & Peptides
Filter     Order     Display # 
Date Item Title
14 Oct 2006 Amgen Receives Complete Response Letter for Extended Dosing of Aranesp(R) for Patients with Chronic Kidney Disease and Anemia
12 Oct 2006 Discovery Labs Announces Topline Results of Surfaxin Phase 2 Clinical Trial for the Prevention and Treatment of BPD
12 Oct 2006 Roche and Trimeris Provide Update on Development of Needle-Free Administration for FUZEON(R)
11 Oct 2006 CoGenesys Initiates Phase 1-2 Clinical Trial of Cardeva in Patients With Heart Failure
11 Oct 2006 Nautilus Biotech Announces IND Filing For Its Injectable Long-Lasting Interferon-Alpha, Belerofon(r)
11 Oct 2006 ConjuChem Initiates Phase I/II Multiple-Dose Study of PC-DAC(TM):Exendin-4
10 Oct 2006 Data from Protalex' Phase I Clinical Trial of PRTX-100 Presented at the American College of Clinical Pharmacology
10 Oct 2006 Alligator Bioscience to Address Immunogenicity With Epibase(R)
10 Oct 2006 Fibrex Medical Initiates Phase II Trial of Treatment for Reperfusion Injury in Myocardial Infarction
07 Oct 2006 Pharming Recieves Orphan Product Grant From US FDA For Rhucin
06 Oct 2006 Agennix Receives FDA Fast Track Designation for Talactoferrin Alfa in Non-Small Cell Lung Cancer and Diabetic Foot Ulcers
06 Oct 2006 Metabolic’s obesity trial update: First 100 subjects complete the Phase 2B trial of AOD9604
06 Oct 2006 Dyax Corp. Announces Funded Research Agreement with Trubion Pharmaceuticals Inc. for Discovery of Therapeutic Proteins
05 Oct 2006 Human Genome Sciences Announces Phase 3 Clinical Development Program For Albuferon(TM) In Chronic Hepatitis C
05 Oct 2006 LAB International Reports Positive Results From Its LAB-CGRP Phase IIa Study
04 Oct 2006 Æterna Zentaris Announces Positive Phase 2 Results for Ozarelix in Benign Prostatic Hyperplasia
03 Oct 2006 GTC Biotherapeutics And LFB Biotechnologies Enter Strategic Collaboration For Recombinant Plasma Proteins And Monoclonal Antibodies
03 Oct 2006 Valeant Pharmaceuticals Previews 24-Week Results of Direct Trial for Infergen(R)
02 Oct 2006 Innovive Pharmaceuticals Discontinues Development Of INNO-105
30 Sep 2006 Nastech Provides Calcitonin Salmon Nasal Spray Complete Response to FDA
30 Sep 2006 Betaferon Demonstrates Robust Reduction in Risk of Developing Multiple Sclerosis Across All Subgroups of BENEFIT study
29 Sep 2006 Discovery Labs Updates Progress On Manufacturing Remediation and Surfaxin FDA Regulatory Matters
28 Sep 2006 One-Year Data From Phase III Trial Show That New Formulation Of Rebif® Offers Substantial Improvement In Tolerability And Immunogenicity Profiles
28 Sep 2006 Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery
28 Sep 2006 Crystallographic Analysis of Anticalin(R) Targeting CTLA-4 Confirms the Excellent Suitability of Pieris' Lipocalin Scaffold to Develop Superior Biotherapeutics
28 Sep 2006 Metabolic’s neuropathic pain drug, ACV1, enters Phase 2 clinical trials
27 Sep 2006 Dermisonics' Test With Type-2 Diabetics Proves Insulin Patch Component of the U-Strip System Does Not Damage the Skin
27 Sep 2006 Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. announce a Collaboration Agreement for the development of two Biopharmaceuticals, based on Protalix's recombinant plant cell expression technology
26 Sep 2006 Phase II results of Org 36286, a new recombinant fertility hormone with sustained activity - Org 36286 will reduce the number of injections needed in IVF and ICSI
26 Sep 2006 Bayer Healthcare AG Animal Health and AplaGen Sign a Cooperation Agreement
22 Sep 2006 European Commission grants mondoBIOTECH’s product Aviptadil the Orphan Designation for treating ALI
22 Sep 2006 Exenatide Receives Positive Opinion From the European Committee for Medicinal Products for Human Use for the Treatment of Type 2 Diabetes
22 Sep 2006 Debiopharm Granted European Orphan Drug Status For Debio-0513 (PTR-262) For Myasthenia Gravis
21 Sep 2006 Avidia Initiates Clinical Trial of Novel Inhibitor of Interleukin-6 for Crohn’s Disease
20 Sep 2006 Nastech Initiates Clinical Development of Rapid Acting Insulin Nasal Spray for Diabetes
20 Sep 2006 Bentley Pharmaceuticals Announces Agreement with Cardinal Health for Scale-Up and Manufacture of Clinical Supplies for Bentley's Intranasal Insulin Program
19 Sep 2006 Serono And Syntonix To Pursue The Development Of A Long-Acting, Inhaleable FSH Therapy To Treat Infertility
19 Sep 2006 Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
19 Sep 2006 NEOPHARM Presents Updated CINTREDEKIN BESUDOTOX Phase I/II Median Survival Data at European Association of Neuro-Oncology (EANO) Meeting
19 Sep 2006 SciClone and Sigma-Tau Present Encouraging Interim Phase 2 Metastatic Malignant Melanoma Response Data
19 Sep 2006 NovoMix(R)30 insulin is an effective and safe alternative to basal–bolus therapy for patients with type 2 diabetes
16 Sep 2006 SciClone's SCV-07 Demonstrates Oral Bioavailability
16 Sep 2006 Further PREDICTIVE™ study results show diabetes can be effectively managed without causing weight gain (15 Sep 2006)
16 Sep 2006 Affymax Announces Publication of Hematide(TM) Phase 1 Trial Results in Blood
15 Sep 2006 Biogen Idec And Mondobiotech Sign Collaboration And Licensing Agreement To Develop And Commercialize Aviptadil For Pulmonary Arterial Hypertension
15 Sep 2006 Liraglutide, a once-daily GLP-1 analogue, shows potential to change course of diabetes
15 Sep 2006 MannKind Corporation Completes Patient Enrollment for the Major Phase 3 Safety Study of Technosphere(R) Insulin in Patients With Diabetes
15 Sep 2006 Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
15 Sep 2006 Drug Delivery specialist celares GmbH starts extensive contract development for Max-Planck-Institute for Infection Biology.
14 Sep 2006 New Treatment a Success for Anaemia Associated With Chronic Kidney Disease
 
<< Start < Prev 21 22 23 24 25 26 27 28 29 Next > End >>
Results 1001 - 1050 of 1426

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics